A Phase II Clinical Trial of ABI-007 (A Cremophor-Free, Protein Stabilized, Nanoparticle Paclitaxel)Administered Weekly in Taxol Resistant Patients With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Jul 2007 Status changed from in progress to completed.
- 17 Sep 2005 New trial record.